Locations:
Min Investment:
Max Investment:
Target Investment:
2024
2023
2023
2023
2020 - 2022
2020 - 2022
Developing personalized adjuvant treatment strategies for early-stage breast cancer.
2020 - 2022
2020 - 2022
Discovery and development of therapeutic biologics targeting the lipid metabolism in order to treat advanced cancer.
2020 - 2022
2020 - 2022
DeepUll is a biotech company that focuses its activity on the development of a new diagnostic system for early-stage sepsis condition.
2020 - 2022
2020 - 2022
Developing innovative medicines to treat patients suffering from Central nervous system (CNS) diseases
2019 - 2022
2019 - 2022
Life sciences venture capital firm
2019 - 2021
2019 - 2021
Development of a new generation of cell penetrating peptides (CPPs) targeting the Myc oncoprotein for cancer treatment.
2018 - 2019
2018 - 2019
Development of novel treatments for severe, orphan diseases of the central nervous system (CNS)